Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | PRCP | P42785 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4876495 | 0.82 | TAAR1 (0.44) | PRCP | |
| SCHEMBL403964 | 0.82 | TAAR1 (0.44) | PRCP | |
| SCHEMBL1095897 | 0.82 | TAAR1 (0.44) | PRCP | |
| SCHEMBL4876501 | 0.82 | TAAR1 (0.44) | PRCP | |
| SCHEMBL12377258 | 0.82 | KMT2A (0.49) | MEN1KMT2APRCP | |
| SCHEMBL401997 | 0.80 | ALDH1A1 (0.60) | MEN1KMT2A | |
| SCHEMBL1912140 | 0.80 | ALDH1A1 (0.60) | MEN1KMT2A | |
| SCHEMBL403886 | 0.78 | MME (0.47) | — | |
| SCHEMBL403418 | 0.78 | ALDH1A1 (0.58) | MEN1KMT2A | |
| SCHEMBL402103 | 0.77 | CTSC (0.54) | PRCP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8101640-B2 | Antibacterial agents | NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US) | 2012-01-24 | — | — | US | disclosed |
| US-20110172174-A1 | Antibacterial agents | NOVARTIS VACCINES AND DIAGNOSTICS INC. | 2011-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172174-A1 | Antibacterial agents | MRPL21, SI, PGLS | MEN1 2414/4885KMT2A 4800/4885PRCP 721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.